(Q54003705)

23 May 2018

title

Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen. (English)

1 reference

23 May 2018

author

Amir H Noormohammadi

1 reference

ORCID Public Data File 2021

author name string

Noormohammadi AH

1

1 reference

23 May 2018

Hochrein H

2

1 reference

23 May 2018

Curtis JM

3

1 reference

23 May 2018

Baldwin TM

4

1 reference

23 May 2018

Handman E

5

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 July 2001

1 reference

23 May 2018

published in

Vaccine

1 reference

23 May 2018

volume

19

1 reference

23 May 2018

issue

28-29

1 reference

23 May 2018

page(s)

4043-4052

1 reference

23 May 2018

TH1 and TH2 cell antigen receptors in experimental leishmaniasis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Immunoregulation by interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Therapy of murine cutaneous leishmaniasis by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Isolation and characterization of infective and non-infective clones of Leishmania tropica

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

A new standard for the assessment of disease progression in murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900132-3

7 January 2021

10.1016/S0264-410X(01)00132-3

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018